He moves to the Swiss biotech from Micromet
Swiss biotech company Cytos Biotechnology has appointed Dr Christian Itin to be its new CEO.
He has also been elected to Cytos' board of directors and will be proposed as its new chairman, succeeding Dr Thomas Hecht, at an extraordinary shareholders meeting next month.
Dr Itin joins Cytos from Micromet, where he served as CEO for eight years until the biopharmaceutical company was acquired by Amgen earlier this year for $1.2bn.
In total he spent 13 years in senior management roles at Micromet, prior to which he co-founded US protein chip company Zyomyx.
Commenting on the appointment Dr Hecht said: “Christian is an experienced biotech leader with significant expertise and a proven track record and his appointment completes our restructuring of Cytos. We believe with his experience and skills that he is well positioned to shape Cytos' future.”
Cytos' board will see a further change next month, when non-executive member, and its former chief financial officer Jakob Schlapbach will set down at the shareholder meeting.